A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Recruiting · NCT07225309 · Interventional (participants receive a specific treatment) · Lead sponsor: Memorial Sloan Kettering Cancer Center
View the official record on ClinicalTrials.gov →Interventions studied
Meaning-Centered Psychotherapy for Latinos /MCP-L
What this trial is about
The purpose of this study is to find out if Meaning-Centered Psychotherapy for Latinos (MCP-L) helps reduce anxiety and depression and improves quality of life compared to cognitive behavioral therapy (CBT). Investigators also want to learn what participants and providers think about the therapy, including how the therapy is designed, outside factors, available resources, and how the people involved affect how well MCP-L works.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- EMR Criteria
- \- Documentation of Disease
- Pathologically confirmed breast, prostate, colorectal, thyroid, cervix, uteri, or lung - solid tumor cancer (either most recent or new diagnosis)
- Definition of Disease \[or Measurable Disease\]
- Diagnosed with stages III or IV
- Prior Treatment
- Receiving ambulatory care at INCan
- Self-Report Criteria
- Age ≥ 18 years
- Able to read and communicate in Spanish determined by the question: "Can you read and communicate in Spanish? Yes/No"
- Professional role of administrators, clinicians (e.g., oncologists), mental health providers, supervised therapists-in-training (e.g., graduate students), or other related provider delivering the MCP-L experimental intervention
- Providing care (or services) to Mexican cancer patients at INCan
- Has access to internet and an electronic device
- Agrees to be audio-recorded
Exclusion criteria
- EMR Criteria
- Prior Treatment
- Received psychological or psychiatric care at INCan in the last 3 months
- In the judgment of the treating physician, protocol investigators, and/or study staff, presence of cognitive impairment (e.g., delirium or dementia) sufficient to preclude meaningful informed consent and/or study participation
- Diagnosed with a serious psychiatric condition
- Self-Report Criteria
- Received psychological or psychiatric care outside of INCan in the last 3 months
- Presence of suicide risk determined by the Columbia-Suicide Severity Rating Scale
- Too ill to participate determined by the question: "Do you feel too ill to participate because of communication problems, uncontrollable pain, or other symptoms that prevent you from participating?"
- Provider Eligibility Criteria:
- Inclusion Criteria Self-Report Criteria
- Age ≥ 18 years
- Able to read and communicate in Spanish determined by the question: "Can you read and communicate in Spanish? Yes/No"
- Professional role of administrators, clinicians (e.g., oncologists), mental health providers, supervised therapists-in-training (e.g., graduate students), or other related provider delivering the MCP-L experimental intervention
- Providing care (or services) to Mexican cancer patients at INCan
- Has access to internet and an electronic device
- Agrees to be audio-recorded
Where it is running
2 locations listed across 1 US state.
- Memorial Sloan Kettering Cancer Center - New York, New York, United States
- Instituto Nacional de Cancerología (INCan) - Mexico City, Mexico